BREAKING
Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 23 hours ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 24 hours ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 1 day ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 5 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 6 days ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 23 hours ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 24 hours ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 1 day ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 5 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 6 days ago
ADVERTISEMENT
AlphaGraphs

Infographic: Highlights of Merck & Co. (MRK)Q4 2020 earnings report

Merck & Co., Inc. (NYSE: MRK) reported weak earnings and sales for the fourth quarter of 2020. Worldwide sales edged up 5% year-over-year to $12.5 billion but failed to match the expectations. Net loss for the quarter was $2.09 billion or $0.83 per share compared to a profit of $2.35 billion or $0.92 per share […]

$MRK February 4, 2021 1 min read
NYSE
$MRK · Earnings

Merck & Co., Inc. (NYSE: MRK) reported weak earnings and sales for the fourth quarter of 2020. Worldwide sales edged up 5% year-over-year to $12.5 billion but failed to match the expectations. Net loss for the quarter was $2.09 billion or $0.83 per share compared to a profit of $2.35 billion or $0.92 per share […]

· February 4, 2021

Merck & Co., Inc. (NYSE: MRK) reported weak earnings and sales for the fourth quarter of 2020.

Worldwide sales edged up 5% year-over-year to $12.5 billion but failed to match the expectations.

Net loss for the quarter was $2.09 billion or $0.83 per share compared to a profit of $2.35 billion or $0.92 per share last year.

The adjusted EPS increased by 17% to $1.32 per share.

  • Merck (MRK) Q2 2020 Earnngs Infograph
  • Merck & Co. announces financial results for first quarter 2020

ADVERTISEMENT
ADVERTISEMENT